Prevalence and health care costs of mitochondrial disease in Ontario, Canada: A population-based cohort study

• Emmalin Buajitti,

  Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliations Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada, ICES, Toronto, Ontario, Canada

  ⨯
• Laura C. Rosella ,

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  * E-mail: laura.rosella@utoronto.ca

  Affiliations Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada, ICES, Toronto, Ontario, Canada, Institute for Better Health, Trillium Health Partners, Mississauga, Ontario, Canada, Department of Laboratory Medicine and Pathology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  https://orcid.org/0000-0003-4867-869X

  ⨯
• Ersi Zabzuni,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• L. Trevor Young,

  Roles Methodology, Writing – review & editing

  Affiliations Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Ana C. Andreazza

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  Affiliations Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada, Mitochondrial Innovation Initiative, MITO2i, University of Toronto, Toronto, Ontario, Canada

  ⨯